Biodegradable scleral implant for intravitreal controlled release of fluconazole

References

• McDonnell, P., McDonnell, J. M., Brown, R. H. and Green, W. R. (1985) Ocular involvement in patients with fungal infections. Ophthalmology, 92, 706–709.
   PubMed Web of Science ®Google Scholar
• Moritera, T., Ogura, Y., Honda, Y., Wada, R., Hyon, S. H. and Ikada, Y. (1991) Microspheres of biodegradable poly-mers as a drug delivery system in the vitreous. Invest. Ophthalmol. Vis. Sci. 32, 1785–1790.
   PubMed Web of Science ®Google Scholar
• Moritera, T., Ogura, Y., Honda, Y., Wada, R., Hyon, S. H. and Ikada, Y. (1992) Biodegradable microspheres con-taining adriamycin in the treatment of proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 33, 3125–3130.
   PubMed Web of Science ®Google Scholar
• Kimura, H., Ogura, Y, Moritera, T., Honda, Y, Wada, R., Hyon, S. H. and Ikada, Y. (1992) Injectable microspheres with controlled drug release for glaucoma filtering surgery. Invest. Ophthalmol. Hs. Sci. 33, 3436–3441.
   PubMed Web of Science ®Google Scholar
• Moritera, T., Ogura, Y., Yoshimura, N., Kuriyama, S., Honda, Y., Tabata, Y. and Ikada, Y. (1994) Feasibility of drug targeting to the retinal pigment epithelium with bio-degradable microspheres. Curr. Eye Res. 13, 171–176.
   PubMed Web of Science ®Google Scholar
• Ogura, Y. and Kimura, H. (1995) Biodegradable polymer microspheres for targeted drug delivery to the retinal pig-ment epithelium. Surv. Ophthalmol. 39, 17–24.
   PubMed Web of Science ®Google Scholar
• Tremblay, C., Barza, M., Szoka, F., Lahav, M. and Baum, J. (1985) Reduced toxicity of liposome-associated ampho-tericin B injected intravitreally in rabbits. Invest. Ophthal-mol. Hs. Sci. 26, 711–718.
   PubMed Web of Science ®Google Scholar
• Fishman, P. H., Peyman, G. A. and Lesar, T. (1986) Intra-vitreal liposomed-encapsulated gentamicin in a rabbit model: Prolonged therapeutic levels. Invest. Ophthalmol. Vis. Sci. 27, 1103–1106.
   PubMed Web of Science ®Google Scholar
• Assil, K. K. and Weinreb, R. N. (1987) Mutivesicular lipo-somes: sustained release of the antimetabolite cytarabine in the eye. Arch. Ophthalmol. 105,400–403.
   PubMedGoogle Scholar
• Barza, M., Stuart, M. and Szoka, F. (1987) Effect of size and lipid composition on the pharmacokinetics of intra-vitreal liposomes. Invest. Ophthalmol. Vis. Sci. 28, 893–900.
   PubMed Web of Science ®Google Scholar
• Peyman, G. A., Khoobehi, B., Tawakol, M., Schulman, J. A., Mortada, H. A., Alkan, H. and Fiscella, R. (1987) Intravit-real injection of liposome-encapsulated ganciclovir in a rabbit model. Retina, 7, 227–229.
   PubMed Web of Science ®Google Scholar
• Joondeph, B. C., Peyman, G. A., Khoobehi, B. and Yue, B. Y. (1988) Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy. Ophthalmic Surg. 19, 252–256.
   PubMedGoogle Scholar
• Kimura, H., Ogura, Y, Hashizoe, M., Nishiwaki, H., Honda, Y. and Ikada, Y (1994) A new vtitreal drug deliv-ery system using an implantable biodegradable polymeric device. Invest. Ophthalmol. Vis. Sci 35, 2815–2819.
   Google Scholar
• Hashizoe, M., Ogura, Y., Kimura, H., Moritera, T., Honda, Y, Kyo, M., Hyon, S. H. and Ikada, Y (1994) Scleral plug of biodegradable polymers for controlled drug delivery in the vitreous. Arch. Ophthalmol. 112, 1380–1384.
   Google Scholar
• Hashizoe, M., Ogura, Y, Takanashi, T., Killion, N., Honda, Y. and Ikada, Y. (1995) Implantable biodegradable poly-meric device in the treatment of experimental proliferative vitreoretinopathy. Curt: Eye Res. 14, 473–477.
   PubMed Web of Science ®Google Scholar
• Kunou, N., Ogura, Y., Hashizoe, M., Honda, Y., Hyon, S. H. and Ikada, Y. (1995) Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits. J Controlled Release, 37,143–150.
   Web of Science ®Google Scholar
• Smith, T. J., Pearson, P. A., Blandford, D. L., Brown, J. D., Goins, K. A., Hollins, J. L., Schmeisser, E. T., Glavinos, P. and Baldwin, L. B. (1992) Intravitreal sustained-release ganciclovir. Arch. Ophthalmol. 110, 255–258.
   PubMed Web of Science ®Google Scholar
• Sanborn, G. E., Anand, R. A., Torti, R E., Nightingale, S. D., Cal, S. X., Yates, B., Ashton, P. and Smith, T. (1992) Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Arch. Ophthalmol. 110, 188–195.
   PubMed Web of Science ®Google Scholar
• Anand, R., Nightingale, S. D., Fish, R. H., Smith, T. J. and Ashton, P. Control of cytomegalovirus retinitis using sus-tained release of intraocular ganciclovir. Arch. Ophthal-mol. 111, 223–227.
   Google Scholar
• Anand, R., Font, R. L., Fish, R. H. and Nightingale, S. D. (1993) Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir. Ophthalmology, 100, 1032–1039.
   PubMed Web of Science ®Google Scholar
• Clarkson, J. G. and Green, W. R. (1979) Endogenous fun-gal endophthalmitis. Clin. Ophthalmol. 3,1–44.
   Google Scholar
• Edwards, J. E., Foos, R. Y. and Montgomerie, J. Z. (1974) Ocular manifestation of candida septicemia: review of 76 cases of hematogenous Candida endophthalmitis. Medi-cine, 53, 47–75.
   PubMed Web of Science ®Google Scholar
• Barrie, T. (1987) The place of elective vitrectomy in the management of patients with Candida endophthalmitis. Graefes Arch. Clin. Exp. Ophthalmol. 225, 107–131.
   PubMed Web of Science ®Google Scholar
• Brod, R. D., Flynn, H. J., Clarkson, J. G., Pflugfelder, S. C., Culbertson, W. W. and Miller, D. (1990) Endogenous Can-dida endophthalmitis: management without intravenous amphotericin B. Ophthalmology, 97, 666–672.
   PubMed Web of Science ®Google Scholar
• Guex, C. Y, Chave, J. P. and Herbort, C. P. (1993) Postpar-tum Candida endophthalmitis treated with flucoazole. Ophthalmologica, 206, 214–215.
   PubMedGoogle Scholar
• Isobe, Y. and Hatano, H. (1992) Study of suppressive effect of intravenous FLCZ on endogenous Candida endophthalmitis in rabbits. Jpn. I Ophthalmol. 36, 23–27.
   PubMedGoogle Scholar
• Urbak, S. F. and Degn, T. (1994) Fluconazole in the man-agement of fungal ocular infections. Ophthalmologica, 208, 147–156.
   PubMed Web of Science ®Google Scholar
• Galgiani, J. N. (1990) Fluconazole, a new antifungal agent. Ann. Intern. Med. 113, 177–179.
   PubMed Web of Science ®Google Scholar
• Grant, S. M. and Clissold, S. P. (1990) Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and sys-temic mycoses. Drugs, 39, 877–916.
   PubMed Web of Science ®Google Scholar
• O'Day, D. M., Foulds, G., Williams, T. E., Robinson, R. D., Allen, R. H. and Head, W. S. (1990) Ocular uptake of flu-conazole following oral administration. Arch. Ophthalmol. 108, 1006–1008.
   PubMed Web of Science ®Google Scholar
• Savani, D. V., Perfect, J. R., Cobo, L. M. and Durack, D. T. (1987) Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob. Agents Chem other. 31, 11–15.
   PubMedGoogle Scholar
• Schulman, J. A., Peyman, G. A., Fiscella, R., Small, G., Coats, M., Wajszczuk, C. P. and Steahly, L. (1987) Toxic-ity of intravitreal injection of fluconazole in the rabbit. Can. J Opthalmol. 304–306.
   PubMedGoogle Scholar